BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15758016)

  • 21. Chemotherapy for glioblastoma multiforme (GBM).
    Roitberg B
    Surg Neurol; 2006 Feb; 65(2):107-8. PubMed ID: 16427394
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 23. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005).
    Jalali R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1622; author reply 1622-3. PubMed ID: 19028293
    [No Abstract]   [Full Text] [Related]  

  • 24. Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.
    Stuplich M; Hadizadeh DR; Kuchelmeister K; Scorzin J; Filss C; Langen KJ; Schäfer N; Mack F; Schüller H; Simon M; Glas M; Pietsch T; Urbach H; Herrlinger U
    J Clin Oncol; 2012 Jul; 30(21):e180-3. PubMed ID: 22689800
    [No Abstract]   [Full Text] [Related]  

  • 25. Recurrent PNET with MGMT methylation responds to temozolomide.
    Oh J; Bilbao JM; Tsao MN; Fazl M; Guiot MC; Del Maestro RF; Perry JR
    Can J Neurol Sci; 2009 Sep; 36(5):654-7. PubMed ID: 19831139
    [No Abstract]   [Full Text] [Related]  

  • 26. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
    Linz U
    Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models.
    Houghton PJ; Stewart CF; Cheshire PJ; Richmond LB; Kirstein MN; Poquette CA; Tan M; Friedman HS; Brent TP
    Clin Cancer Res; 2000 Oct; 6(10):4110-8. PubMed ID: 11051264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice.
    Kokkinakis DM; Hoffman RM; Frenkel EP; Wick JB; Han Q; Xu M; Tan Y; Schold SC
    Cancer Res; 2001 May; 61(10):4017-23. PubMed ID: 11358820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
    Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
    Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide.
    Beauchesne P
    J Clin Oncol; 2002 Jul; 20(14):3180-1; author reply 3181. PubMed ID: 12118035
    [No Abstract]   [Full Text] [Related]  

  • 32. [New place of the chemotherapy in gliomas].
    Chinot O
    Bull Cancer; 2005 Apr; 92(4):343-54. PubMed ID: 15888391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant therapy in glioblastomas: false steps and real advances.
    Brandes AA; Tosoni A; Franceschi E
    Expert Rev Anticancer Ther; 2007 May; 7(5):607-8. PubMed ID: 17492923
    [No Abstract]   [Full Text] [Related]  

  • 34. Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
    Ramachandran C; Nair SM; Escalon E; Melnick SJ
    J Complement Integr Med; 2012 Aug; 9():Article 20. PubMed ID: 22944718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy for glioblastoma: the devil is in the details.
    Lesniak MS
    J Clin Oncol; 2011 Aug; 29(22):3105; author reply 3105-6. PubMed ID: 21709193
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent medical management of glioblastoma.
    Johnson DR; Chang SM
    Adv Exp Med Biol; 2012; 746():26-40. PubMed ID: 22639157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
    Mirimanoff RO; Gorlia T; Mason W; Van den Bent MJ; Kortmann RD; Fisher B; Reni M; Brandes AA; Curschmann J; Villa S; Cairncross G; Allgeier A; Lacombe D; Stupp R
    J Clin Oncol; 2006 Jun; 24(16):2563-9. PubMed ID: 16735709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In reply to Gondi and Mehta.
    Huang J; Robinson CG; Badiyan SN
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):454-5. PubMed ID: 25636773
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of newly diagnosed glioblastoma multiforme.
    Nieder C
    J Clin Oncol; 2002 Jul; 20(14):3179-80; author reply 3181-2. PubMed ID: 12118034
    [No Abstract]   [Full Text] [Related]  

  • 40. In Regard to Arvold et al.
    Fiorica F; Colella M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):939. PubMed ID: 26530769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.